Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interim analyses in clinical trials: classical vs. Bayesian approaches.

D A Berry

    Statistics in Medicine
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

    Breast cancer research and treatment·2016
    Same author

    Emerging innovations in clinical trial design.

    Clinical pharmacology and therapeutics·2015
    Same author

    The Signature Program: Bringing the Protocol to the Patient.

    Clinical pharmacology and therapeutics·2015
    Same author

    CYP2D6 genotype and adjuvant tamoxifen.

    Clinical pharmacology and therapeutics·2014
    Same author

    Assessment of local vocal fold deformation characteristics in an in vitro static tensile test.

    The Journal of the Acoustical Society of America·2011
    Same journal

    Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

    Statistics in medicine·2026
    Same journal

    Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

    Statistics in medicine·2026
    Same journal

    Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

    Statistics in medicine·2026
    Same journal

    A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

    Statistics in medicine·2026
    Same journal

    Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

    Statistics in medicine·2026
    Same journal

    Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

    Statistics in medicine·2026
    See all related articles

    This study recommends a Bayesian approach for interim analysis in clinical trials, stopping early when one treatment is likely superior. This Bayesian method offers advantages over classical hypothesis testing for efficient trial design.

    Area of Science:

    • Biostatistics
    • Clinical Trial Methodology
    • Statistical Inference

    Background:

    • Interim analysis in clinical trials allows for early stopping based on accumulating data.
    • Classical hypothesis testing approaches can be suboptimal for sequential decision-making in trials.
    • Bayesian inference offers a flexible framework for updating evidence during a trial.

    Purpose of the Study:

    • To critically evaluate classical hypothesis testing for interim analysis in two-treatment clinical trials.
    • To propose and recommend a Bayesian approach for sequential monitoring and early stopping.
    • To assess the efficiency gains of the Bayesian method in terms of average sample size.

    Main Methods:

    • Comparison of classical and Bayesian inference frameworks for interim analysis.

    Related Experiment Videos

  • Development of a Bayesian sequential stopping rule based on treatment superiority probability.
  • Application to normal distribution data analyzed in stages.
  • Evaluation of average sample number (ASN) as a function of the number of interim analyses.

    • Main Results:

    • Classical hypothesis testing is criticized for its limitations in the context of interim analysis.
    • The recommended Bayesian approach provides a clear stopping criterion based on posterior probabilities.
    • The study quantifies the potential reduction in sample size achievable with the Bayesian method.

    Conclusions:

    • A Bayesian framework is recommended for interim analysis in clinical trials due to its coherent decision-making.
    • The proposed Bayesian method allows for efficient early stopping, potentially reducing trial duration and cost.
    • The gain in average sample number demonstrates the practical advantages of this Bayesian approach.